Cargando…
Dose-escalation of oxaliplatin in hemodialysis patient treated with FOLFOX therapy: A case report
RATIONALE: Oxaliplatin is a key part of the standard treatment for colorectal cancer which is formally contraindicated in patients with severe renal dysfunction. Here, we investigated a safe and efficient dosing schedule of oxaliplatin in folinic acid, fluorouracil, and oxaliplatin (FOLFOX) regimen...
Autores principales: | Wang, Danping, Li, Xiaofei, Xu, Lingyan, Fang, Wentong, Cai, Xiaomin, Wang, Ying, Wang, Jiawei, Wang, Yuanyuan, Zhao, Fengjiao, Gu, Yanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946187/ https://www.ncbi.nlm.nih.gov/pubmed/31689749 http://dx.doi.org/10.1097/MD.0000000000017462 |
Ejemplares similares
-
Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy
por: Chen, Jianfang, et al.
Publicado: (2016) -
Loco-regional outcomes of adjusted breast radiotherapy with conventional fractionation after breast conserving surgery: De-escalation of whole breast irradiation dose
por: Kim, Sang-Won, et al.
Publicado: (2020) -
The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancer: A meta-analysis
por: Dai, Jiali, et al.
Publicado: (2019) -
Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer
por: Park, Dawon, et al.
Publicado: (2018) -
Chemotherapy in patient with colon cancer after renal transplantation: A case report with literature review
por: Fang, Wentong
Publicado: (2018)